In order to test this hypothesis, we included five cell lines (MYCN non-amplified neuroblastoma cells: Sk-N-AS and SH-SY5Y; MYCN-amplified neuroblastoma cells: CHP-212, Sk-N-BE(2) and IMR-32) (Figure 5A). The gene discussed is MYCN; the disease is neuroblastoma.